(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEURAPTIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEURAPTIVE

ST13

US500000087749824

Class

5, 10

Filing

87749824

Registration

6622802

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

01/18/2022

Trademark type

Word

Nice classes

5, 10

Filing date

01/10/2018

Registration date

01/18/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/18/2022

Last transaction

01/18/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/24/2020

First use in commerce

09/24/2020

Drawing code

4

Owner type

03

Owner location

Louisville, CO, US

Examiner

ALLEN, BIANCA LEIGH

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc.

Representatives

Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; surgical implants comprised of biological material derived from human or animal tissueused to protect or repair tissue of the peripheral or central nervous system

Class 10

medical device for preparing tissue of the peripheral or central nervous system for surgery; surgical implants comprised of synthetic artificial materialused to protect or repair tissue of the peripheral or central nervous system

Publications

History of USPTO decisions and trademark events.

42 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

01/18/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/14/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/13/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/18/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/10/2021

EX4G

SOU EXTENSION 4 GRANTED

03/09/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/08/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/17/2021

IUAF

USE AMENDMENT FILED

02/02/2021

EXT4

SOU EXTENSION 4 FILED

02/02/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/02/2021

EISU

TEAS STATEMENT OF USE RECEIVED

02/02/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/06/2020

EX3G

SOU EXTENSION 3 GRANTED

08/04/2020

EXT3

SOU EXTENSION 3 FILED

08/04/2020

EEXT

SOU TEAS EXTENSION RECEIVED

08/04/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/06/2020

EX2G

SOU EXTENSION 2 GRANTED

02/04/2020

EXT2

SOU EXTENSION 2 FILED

02/04/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/04/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/07/2019

EX1G

SOU EXTENSION 1 GRANTED

08/05/2019

EXT1

SOU EXTENSION 1 FILED

08/05/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/05/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/12/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/16/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/16/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/18/2018

PUBO

PUBLISHED FOR OPPOSITION

12/18/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/28/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/09/2018

ALIE

ASSIGNED TO LIE

11/09/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/25/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/24/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/23/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/23/2018

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

04/27/2018

GPRA

PRIORITY ACTION E-MAILED

04/27/2018

CPRA

PRIORITY ACTION WRITTEN

04/27/2018

DOCK

ASSIGNED TO EXAMINER

04/20/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/24/2018

NWAP

NEW APPLICATION ENTERED

01/13/2018

Continuous trademark protection

Get notified about every new filing that threatens NEURAPTIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.